Avior Wealth Management LLC acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 34,400 shares of the medical instruments supplier's stock, valued at approximately $546,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Signaturefd LLC lifted its position in DENTSPLY SIRONA by 166.9% in the 2nd quarter. Signaturefd LLC now owns 6,283 shares of the medical instruments supplier's stock worth $100,000 after buying an additional 3,929 shares during the last quarter. Public Employees Retirement System of Ohio lifted its position in DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier's stock worth $983,000 after buying an additional 861 shares during the last quarter. IMS Capital Management bought a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $219,000. Ballentine Partners LLC lifted its position in DENTSPLY SIRONA by 114.9% in the 2nd quarter. Ballentine Partners LLC now owns 30,232 shares of the medical instruments supplier's stock worth $480,000 after buying an additional 16,167 shares during the last quarter. Finally, Fifth Third Bancorp lifted its position in DENTSPLY SIRONA by 6.0% in the 2nd quarter. Fifth Third Bancorp now owns 31,113 shares of the medical instruments supplier's stock worth $494,000 after buying an additional 1,750 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.
DENTSPLY SIRONA Stock Performance
Shares of XRAY stock opened at $12.61 on Tuesday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company has a market capitalization of $2.52 billion, a P/E ratio of -2.66, a PEG ratio of 0.78 and a beta of 0.96. The stock has a 50 day moving average price of $14.08 and a two-hundred day moving average price of $14.79. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.14 and a fifty-two week high of $27.16.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm's revenue for the quarter was down 4.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
DENTSPLY SIRONA Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is currently -13.50%.
Wall Street Analyst Weigh In
XRAY has been the subject of a number of recent research reports. Wall Street Zen upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Friday. UBS Group lowered their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Stifel Nicolaus lowered their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Finally, Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $18.64.
Read Our Latest Research Report on DENTSPLY SIRONA
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
